Hipercolesterolemia

Publicado por:British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; The Stroke Association

Publicado por última vez:2014

Europa

Consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance

Publicado por:European Atherosclerosis Society

Publicado por última vez:2023

2021 ESC guidelines on cardiovascular disease prevention in clinical practice

Publicado por:European Society of Cardiology

Publicado por última vez:2021

2019 ESC/EAS guidelines for the management of dyslipidaemias

Publicado por:European Society of Cardiology; European Atherosclerosis Society

Publicado por última vez:2019

América del Norte

2022 ACC Expert Consensus Decision Pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee

Publicado por:American College of Cardiology

Publicado por última vez:2022

2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults

Publicado por:Canadian Cardiovascular Society

Publicado por última vez:2021

Lipid management in patients with endocrine disorders: an Endocrine Society clinical practice guideline

Publicado por:Endocrine Society

Publicado por última vez:2020

VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction

Publicado por:Veterans Health Administration

Publicado por última vez:2020

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the management of dyslipidemia and prevention of cardiovascular disease algorithm - 2020 executive summary

Publicado por:American Association of Clinical Endocrinologists; American College of Endocrinology

Publicado por última vez:2020

ACC/AHA guideline on the primary prevention of cardiovascular disease

Publicado por:American College of Cardiology; American Heart Association

Publicado por última vez:2019

Dietary cholesterol and cardiovascular risk: a science advisory from the American Heart Association

Publicado por:American Heart Association

Publicado por última vez:2019

Primary prevention of ASCVD and T2DM in patients at metabolic risk

Publicado por:Endocrine Society

Publicado por última vez:2019

AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol

Publicado por:American Heart Association; American College of Cardiology

Publicado por última vez:2018

AHA/ACC/AACVPR/AAPA/ABC/ACPM/ ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol

Publicado por:American Heart Association; American College of Cardiology

Publicado por última vez:2018

Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease

Publicado por:American Heart Association; American College of Cardiology

Publicado por última vez:2018

AACE/ACE guidelines for management of dyslipidemia and prevention of cardiovascular disease

Publicado por:American Association of Clinical Endocrinologists; American College of Endocrinology

Publicado por última vez:2017

Resto del mundo

Global recommendations for the management of dyslipidemia

Publicado por:International Atherosclerosis Society

Publicado por última vez:2014

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad